Doxorubicin-induced cardiotoxicity and risk factors
Doxorubicin (DOX) is an anthracycline antibiotic widely used as a chemotherapeutic agent to treat solid tumours and hematologic malignancies. Although useful in the treatment of cancers, the benefit of DOX is limited due to its cardiotoxic effect that is observed in a large number of patients. In th...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2024-02-01
|
| Serie: | International Journal of Cardiology: Heart & Vasculature |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S235290672300163X |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|